Hybrids of small CD4 mimics and gp41-related peptides as dual-target HIV entry inhibitors

Wang, Rongyi; Tsuji, Kohei; Kobayakawa, Takuya; Yoshimura, Kazuhisa; Matsushita, Shuzo; Harada, Shigeyoshi; Tamamura, Hirokazu

doi:10.1016/j.bmc.2022.117083

Bioorganic & Medicinal Chemistry

2022

DOI: 10.1016/j.bmc.2022.117083

|View full text |Cite

Hybrids of small CD4 mimics and gp41-related peptides as dual-target HIV entry inhibitors

Rongyi Wang

Kohei Tsuji

Takuya Kobayakawa

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Preprint1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 70 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

M01 tool: An automated, comprehensive computational tool for generating small molecule-peptide hybrids and docking them into curated protein structures

Sheikholeslami,

Nazari,

Fassihi

2024

Preprint

View full text Add to dashboard Cite

The field of computational drug design is rapidly advancing, necessitating innovative methods to enhance the efficiency and accuracy of ligand-receptor interactions. We introduce M01 tool, a comprehensive computational package designed to facilitate the generation and docking of small molecule-peptide hybrids. M01 tool integrates several established tools, including RDKit and EasyDock, into a user-friendly platform that automates the workflow from hybrid generation to docking simulations. Key features include an intuitive interface for visualizing molecules and selecting connection points, automated receptor preparation from UniProt or PDB IDs, generation of default docking configuration files, ligand preparation and docking using EasyDock, and calculation of molecular descriptors related to ADMET (absorption, distribution, metabolism, excretion, and toxicity) properties. M01 tool aims to simplify the use of advanced computational tools for researchers with limited chemistry expertise, providing a robust and streamlined solution for hybrid design and docking studies. Validation using peptide-alkoxyamine hybrids demonstrated M01 tool's capability to generate and dock over 8,000 unique hybrid molecules, confirming its potential as a powerful tool in drug design.

show abstract

M01 tool: An automated, comprehensive computational tool for generating small molecule-peptide hybrids and docking them into curated protein structures

Sheikholeslami,

Nazari,

Fassihi

2024

Preprint

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Hybrids of small CD4 mimics and gp41-related peptides as dual-target HIV entry inhibitors

Cited by 1 publication

References 70 publications

M01 tool: An automated, comprehensive computational tool for generating small molecule-peptide hybrids and docking them into curated protein structures

M01 tool: An automated, comprehensive computational tool for generating small molecule-peptide hybrids and docking them into curated protein structures

Contact Info

Product

Resources

About